Skip to main content
Equibles

Geneos Wealth Management Inc.

Position in GLSI — Greenwich LifeSciences, Inc.

CIK 1764754 ENGLEWOOD, CO
Back to GLSI Full portfolio

Position in GLSI

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$2,064
-$49 QoQ
Shares Held
88
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 57 holders
Holding Since
Jun 2023
13 quarters on record

Common Shares in GLSI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Geneos Wealth Management Inc. holds $3,299,056 across 37 Biotechnology names. GLSI ranks #26 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GALT
Galectin Therapeutics Inc
 240,427 $1,115,581
2 HALO
Halozyme Therapeutics, Inc.
 12,199 $954,815
3 TWST
Twist Bioscience Corp
 5,300 $545,264
4 AVXL
Anavex Life Sciences Corp.
 48,100 $124,579
5 REGN
Regeneron Pharmaceuticals, Inc.
 137 $85,424
6 TGTX
Tg Therapeutics, Inc.
 1,269 $69,718
7 IBRX
ImmunityBio, Inc.
 5,754 $50,376
8 VRTX
Vertex Pharmaceuticals Inc / Ma
 101 $50,169

All Filings in GLSI

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,064 88
2026-03-31 $2,113 88
2025-12-31 $1,848 88
2025-09-30 $875 88
2025-06-30 $798 88
2025-03-31 $839 88
2024-12-31 $988 88
2024-09-30 $1,264 88
2024-06-30 $1,518 88
2024-03-31 $1,754 88
2023-12-31 $925 88
2023-09-30 $777 88
2023-06-30 $848 88